Abbvie Inc Revenue per Employee (ABBV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Abbvie Inc   (NYSE: ABBV)
 

Abbvie Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 12.43% in the first quarter 2026, year on year to cumulative value of $62,819 million, Abbvie Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,102,088, this marks a new company high.
Within the Healthcare sector Employees of 52 other companies have achieved higher revenue per employee. While Abbvie Inc 's total ranking has deteriorated compared to the previous quarter from 293 to 598. Abbvie Inc has 57,000 employees.


What is Sales per Employee Ratio?







ABBV Revenue per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Revenue Change 12.43 % 10.04 % 9.1 % 6.65 % 8.39 %
Sales per Employee (TTM) $ 1,102,088 1,072,982 1,046,386 1,023,298 1,006,439
ABBV's Total Ranking # 598 # 293 # 275 # 294 # 589
Seq. Revenue Change -9.72 % 5.34 % 2.29 % 15.59 % -11.65 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 35
Healthcare Sector # 53
Overall Market # 598

Revenue per Employee Statistics
High Average Low
$ 1,102,088 $ 685,615 $ 333,754
(Mar 31 2026)   (March 31, 2014)



Financial Statements
Abbvie Inc 's Revenue MRQ $ 15,002 Millions Visit ABBV's Income Statement
Abbvie Inc 's Revenues TTM $ 62,819 Millions Visit ABBV's aggregate revenue growth
What are ABBV's Sales? Visit ABBV's Sales by Segment




Other Ratios
Abbvie Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ABBV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ABBV's Competitors
Revenue per Employee for ABBV's Suppliers
Revenue per Employee for ABBV's Customers

You may also want to know
ABBV's Sales Growth Rates ABBV's Pe Price to earnings ratio ABBV's Receivables Turnover Ratio ABBV's Stock Quote
ABBV's Net Income Growth Rates ABBV's Ps Price to Sales ratio ABBV's Sales per Employee ABBV's Asset Turnover Ratio
ABBV's Net Margin ABBV's Pb Price to Book ratio ABBV's Financial Strength Ratios ABBV's Dividend Payout Ratio
Date modified: 2026-09-08T15:18:59+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Assertio Holdings inc   1,927,509.43 $ 102.158  Million 53 
Siga Technologies Inc  1,913,809.53 $ 93.777  Million 49 
Prestige Consumer Healthcare Inc   1,909,785.96 $ 1,088.578  Million 570 
Zevra Therapeutics Inc   1,886,442.62 $ 115.073  Million 61 
Incyte Corporation  1,885,028.13 $ 5,361.020  Million 2,844 
Privia Health Group Inc   1,832,456.77 $ 2,246.592  Million 1,226 
Tg Therapeutics Inc   1,755,260.65 $ 700.349  Million 399 
Gilead Sciences Inc   1,749,176.47 $ 29,736.000  Million 17,000 
Collegium Pharmaceutical Inc   1,747,635.93 $ 739.250  Million 423 
Rigel Pharmaceuticals Inc  1,722,798.85 $ 299.767  Million 174 
Alnylam Pharmaceuticals Inc   1,714,769.20 $ 4,286.923  Million 2,500 
Atara Biotherapeutics Inc   1,681,428.57 $ 23.540  Million 14 
Xenetic Biosciences Inc   1,595,036.50 $ 3.190  Million
Soleno Therapeutics Inc  1,565,978.02 $ 285.008  Million 182 
Neurocrine Biosciences Inc   1,551,200.00 $ 3,102.400  Million 2,000 
Jazz Pharmaceuticals Plc  1,535,863.32 $ 4,438.645  Million 2,890 
Mirum Pharmaceuticals Inc   1,531,206.99 $ 569.609  Million 372 
Agenus Inc  1,529,209.88 $ 123.866  Million 81 
Progyny Inc   1,510,233.64 $ 1,292.760  Million 856 
Apellis Pharmaceuticals Inc   1,495,642.76 $ 1,105.280  Million 739 
Bristol myers Squibb Company  1,491,753.85 $ 48,482.000  Million 32,500 
Fennec Pharmaceuticals Inc   1,457,114.29 $ 50.999  Million 35 
Tarsus Pharmaceuticals Inc   1,446,159.46 $ 535.079  Million 370 
Eli Lilly And Company  1,444,990.00 $ 72,249.500  Million 50,000 
Esperion Therapeutics Inc   1,422,598.64 $ 418.244  Million 294 
Krystal Biotech Inc   1,414,589.83 $ 417.304  Million 295 
Acadia Pharmaceuticals Inc   1,372,493.73 $ 1,095.250  Million 798 
Liquidia Corporation  1,333,634.26 $ 288.065  Million 216 
Biogen Inc   1,324,986.67 $ 9,937.400  Million 7,500 
Lantheus Holdings Inc   1,295,200.34 $ 1,545.174  Million 1,193 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.